Overall Status

Recruiting (2)

Active, not recruiting (1)

Phase

phase 2 (2)

phase 1 (1)

Sponsor

City of Hope Medical Center (1)

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

duvelisib (1)

extracorporeal photopheresis (1)

mogamulizumab (1)

nivolumab (1)

pembrolizumab (1)

punch biopsy (1)

quality-of-life assessment (1)

questionnaire administration (1)

Study Documents

Intervention Type

biological (3)

procedure (2)

drug (1)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

stage iib mycosis fungoides and sezary syndrome ajcc v8

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting

Folliculotropic Mycosis Fungoides
+7 more

Extracorporeal Photopheresis
+3 more

Duarte, California

City of Hope Medical Center

Dec 8, 2022

Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV

Recruiting

Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
+2 more

Duvelisib
+2 more

Phoenix, Arizona
+11 more

Aug 6, 2022

Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)

Recruiting

Mycosis Fungoides
+12 more

Pembrolizumab

Jacksonville, Florida

Mayo Clinic in Florida

Mar 22, 2022